Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-25

Clinical Trial Update: Biomarker Study in Pancreatic Neuroendocrine Tumours

View source ↗

Summary

An update on a biomarker study in pancreatic neuroendocrine tumors sponsored by Uppsala University; the current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Uppsala University | Conditions: Neuroendocrine Tumors | Status: UNKNOWN